ISSN: 1076-0296

Journal Home

Journal Guideline

Clinical and Applied Thrombosis/Hemostasis Q2 Unclaimed

SAGE Publications Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical and Applied Thrombosis/Hemostasis is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 63. It has an SJR impact factor of 0,633 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,633.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q2) Medicine (miscellaneous) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Clinical and Applied Thrombosis/Hemostasis

0,633

SJR Impact factor

63

H Index

165

Total Docs (Last Year)

531

Total Docs (3 years)

5594

Total Refs

1277

Total Cites (3 years)

488

Citable Docs (3 years)

2.21

Cites/Doc (2 years)

33.9

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

A Machine Learning-Based Model to Predict Acute Traumatic Coagulopathy in Trauma Patients Upon Emergency Hospitalization

A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor

Prognostic Value of the Neutrophil-Lymphocyte Ratio in Patients With ST-Elevated Acute Myocardial Infarction

Application of High-Throughput Sequencing in the Diagnosis of Inherited Thrombocytopenia

Prognostic Value of Treatment Setting in Patients With Cancer Having Pulmonary Embolism: Comparison With the Pulmonary Embolism Severity Index

Effects of Hyperbaric and Decompression Stress on Blood Coagulation and Fibrinolysis

Microparticle Surface Proteins Are Associated With Experimental Venous Thrombosis: A Preliminary Study

Venous Thromboembolism in Patients Undergoing Shoulder Arthroscopy

Evaluation of the Prothrombin Time for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls

Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients

Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome

Probable Warfarin and Dapsone Interaction

SHOW MORE ARTICLES

Prevalence of JAK2V617F mutation in deep venous thrombosis patients and its clinical significance as a thrombophilic risk factor

Joint Bleeding Tendencies in Adult Patients With Hemophilia: It's Not All Pharmacokinetics

Risk Characteristics of Venous Thromboembolism in Chinese Patients

Do Postliver Transplant Patients Need Thromboprophylactic Anticoagulation?

Is Mean Platelet Volume a New Predictor in Confirming a Diagnosis of Acute Appendicitis?

Clopidogrel Provides Significantly Greater Inhibition of Platelet Activity Than Aspirin When Combined With Atorvastatin After Coronary Artery Bypass Grafting: A Prospective Randomized Study

Antiphospholipid Antibodies and Procoagulant Profile in Tunisians With Inflammatory Bowel Diseases

The Trends in Utilizing Nonvitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation

Red Blood Cell Distribution Width in Patients With Cryptogenic Stroke

Left Ventricular Assist Device-Induced Coagulation and Platelet Activation and Effect of the Current Anticoagulant Therapy Regimen

Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia

Management Strategies for Vitamin K Antagonists Reversal in Patients With Major Bleeding